Evidence map›Paper›PMID 33615393›Full record

ArticleWorld journal of urology2021

The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019.

Jakhongir F Alidjanov, Tommaso Cai, Riccardo Bartoletti, Gernot Bonkat, Franck Bruyère, Béla Köves, Ekaterina Kulchavenya, José Medina-Polo, Kurt Naber, Tamara Perepanova and 4 more

Open access · hybridAbstract readComparative StudyMulticenter Study
In one paragraph

Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Perineal prostate biopsy].Urologie (Heidelberg, Germany) · 2024
    Review
  7. Microbiology of infection-related complications after transrectal ultrasound-guided prostate biopsy.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  8. Article
  9. Antimicrobial prophylaxis: To do or not to do? This is the question.Prostate cancer and prostatic diseases · 2024
    Article
  10. Article
  11. Complication rates of ciprofloxacin alone vs. ciprofloxacin plus fosfomycin for transrectal prostate biopsy.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 7 countries.

Jakhongir F Alidjanov *Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Giessen, Germany.ORCID http://orcid.org/0000-0003-2531-4877
Tommaso Cai *Department of Urology, Santa Chiara Hospital, Trento, Italy.ORCID http://orcid.org/0000-0002-7234-3526
Riccardo BartolettiDepartment of Urology, University of Pisa, Pisa, Italy.ORCID http://orcid.org/0000-0002-0021-0302
Gernot BonkatDepartment of Urology, Alta Uro AG, Basel, Switzerland.ORCID http://orcid.org/0000-0002-7298-6468
Franck BruyèreUrologie, CHU Bretonneau, Tours, France.ORCID http://orcid.org/0000-0002-9281-9421
Béla KövesDepartment of Urology, South-Pest Teaching Hospital, Budapest, Hungary.ORCID http://orcid.org/0000-0001-6886-0750
Ekaterina KulchavenyaUrogenital Department, Novosibirsk Research TB Institute, Koves Str 1. 1204, Budapest, 630040, Novosibirsk, Russian Federation.ORCID http://orcid.org/0000-0001-7965-2711
José Medina-PoloDepartment of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0003-3626-8669
Kurt NaberSchool of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-1304-5403
Tamara PerepanovaDepartment of Urinary Tract Infections and Clinical Pharmacology N.A, Lopatkin Scientific Research Institute of Urology and Interventional Radiology, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.ORCID http://orcid.org/0000-0002-2877-0029
Adrian PilatzClinic for Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Giessen, Germany.ORCID http://orcid.org/0000-0001-8072-1841
Zafer TandogduDepartment of Urology, University College London Hospitals, London, UK.ORCID http://orcid.org/0000-0002-5309-3656
Truls E Bjerklund Johansen *Department of Urology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-3490-6460
Florian M Wagenlehner *Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Giessen, Germany. florian.wagenlehner@chiru.med.uni-giessen.de.ORCID http://orcid.org/0000-0002-2909-0797
Justus-Liebig-Universität Gießen · DEHospital Universitario 12 De Octubre · ESMinistry of Health of the Russian Federation · RUNovosibirsk Tuberculosis Research Institute · RUOslo University Hospital · NOOspedale Santa Chiara · ITRoyal London Hospital · GBTechnical University of Munich · DEUniversité de Tours · FRUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate and report the complications, and to analyse antimicrobial stewardship aspects following prostate biopsies (P-Bx) based on the data from a 9-year global study.

methodsThe primary outcome was to compare complications after P-Bx between patients of two cohorts: 2010-2014 and 2016-2019. Primary outcomes included symptoms of lower and severe/systemic urinary tract infection (LUTIS and SUTIS, respectively), and positive urine culture. Readmission to hospital after P-Bx, need for additional antimicrobial therapy, consumption of different antimicrobial agents for prophylaxis and therapy were evaluated. Students t test and chi-square test were used for comparative analyses.

resultsOutcome data were available for 1615 men. Fluoroquinolones-based prophylaxis rate increased from 72.0% in 2010-2014 to 78.6% in 2015-2019. Overall rates of complications increased from 6 to 11.7% including an increase in symptomatic complications from 4.7 to 10.2%, mainly due to an increase in LUTIS. Rates of patients seeking additional medical help in primary care after P-Bx increased from 7.4 to 14.4%; cases requiring post P-Bx antibiotic treatment increased from 6.1 to 9.7%, most of which received fluoroquinolones. Transperineal P-Bx was significantly associated with LUTIS. Following transrectal P-Bx, 2.8% developed febrile infections and 4.0% required hospitalisation. Two men (0.12%) died after transrectal P-Bx due to sepsis.

conclusionsThe rates of complications after P-Bx tended to increase in time, as well as rates of patients seeking additional medical help in the post-P-Bx period. To reduce the risk of infectious complications and to comply with the principles of antibiotic stewardship, clinicians should switch to the transperineal biopsy route.

Indexed as

Antibiotic ProphylaxisAntimicrobial StewardshipAgedBiopsyCross-Sectional StudiesGlobal HealthHumansMaleMiddle AgedPostoperative ComplicationsProspective StudiesProstateTime FactorsUrinary Tract InfectionsAntibiotic resistanceAntibioticsFluoroquinolonesProstate biopsyProstate cancer

Identifiers

PMID33615393
PMCPMC8510929
OpenAlexW3130238271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.